VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$3.19
+0.10 (+3.24%)
Open$3.10
Previous Close$3.09
Day High$3.41
Day Low$3.10
52W High$9.82
52W Low$3.08
Volume—
Avg Volume41.0K
Market Cap64.88M
P/E Ratio—
EPS$-1.67
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+200.6% upside
Current
$3.19
$3.19
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 67.92M | 43.00M | 35.73M |
| Net Income | -34,147,893 | -19,458,720 | 6.74M |
| Profit Margin | -50.3% | -47.8% | 18.9% |
| EBITDA | -25,264,682 | -15,196,560 | 12.85M |
| Free Cash Flow | — | — | 8.80M |
| Rev Growth | +57.9% | +57.9% | +7.9% |
| Debt/Equity | 0.04 | 0.04 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |